Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beam Therapeutics (BEAM) Prepaid Assets (2019 - 2025)

Beam Therapeutics (BEAM) has disclosed Prepaid Assets for 7 consecutive years, with $23.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Prepaid Assets fell 14.34% to $23.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $23.5 million, a 14.34% decrease, with the full-year FY2025 number at $23.5 million, down 14.34% from a year prior.
  • Prepaid Assets was $23.5 million for Q4 2025 at Beam Therapeutics, roughly flat from $23.6 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $27.7 million in Q1 2025 to a low of $7.4 million in Q4 2021.
  • A 5-year average of $19.3 million and a median of $21.2 million in 2023 define the central range for Prepaid Assets.
  • Peak YoY movement for Prepaid Assets: skyrocketed 100.57% in 2022, then decreased 17.88% in 2024.
  • Beam Therapeutics' Prepaid Assets stood at $7.4 million in 2021, then surged by 100.57% to $14.8 million in 2022, then skyrocketed by 43.39% to $21.2 million in 2023, then grew by 29.49% to $27.4 million in 2024, then dropped by 14.34% to $23.5 million in 2025.
  • Per Business Quant, the three most recent readings for BEAM's Prepaid Assets are $23.5 million (Q4 2025), $23.6 million (Q3 2025), and $25.1 million (Q2 2025).